0001213900-24-006959.txt : 20240126 0001213900-24-006959.hdr.sgml : 20240126 20240126160020 ACCESSION NUMBER: 0001213900-24-006959 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240124 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OptimizeRx Corp CENTRAL INDEX KEY: 0001448431 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 261265381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38543 FILM NUMBER: 24567667 BUSINESS ADDRESS: STREET 1: 260 CHARLES STREET STREET 2: SUITE 302 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 248-651-6558 MAIL ADDRESS: STREET 1: 260 CHARLES STREET STREET 2: SUITE 302 CITY: WALTHAM STATE: MA ZIP: 02453 8-K 1 ea192296-8k_optimizerx.htm CURRENT REPORT
false 0001448431 0001448431 2024-01-24 2024-01-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): January 24, 2024

 

OptimizeRx Corporation

(Exact name of registrant as specified in charter)

 

Nevada   001-38543   26-1265381
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

260 Charles Street, Suite 302, Waltham, MA   02453
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 248.651.6568

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 Par Value   OPRX   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective January 24, 2024, Gus Halas retired from his position as Chairperson of the Board of Directors (the “Board”) of OptimizeRx Corporation (the “Company”). Effective January 24, 2024, the Board appointed Lynn O’Connor Vos, a director of the Company, to serve as Chairperson of the Board, as well as a member of the Board’s Nominating & Governance Committee, Compensation Committee, and Audit Committee.

 

Effective January 24, 2024, the Board increased the size of the Board to seven (7) members and, upon the recommendation of the Board’s Nominating & Governance Committee, appointed Catherine M. Klema to serve as a director of the Company until the date of the Company’s 2024 annual meeting of stockholders and until her successor is elected and qualified, except in the event of her earlier death, resignation or removal. The Board also appointed Ms. Klema to serve as a member of the Audit Committee and the Compensation Committee of the Board.

 

As a non-employee director, Ms. Klema will participate in the Company’s previously disclosed non-employee director compensation program, which includes, among other things, an annual cash retainer of $40,000, an annual equity grant with a grant date value of approximately $150,000, an additional annual cash retainer of $10,000 for serving as an Audit Committee Member and an additional annual cash retainer of $5,000 for serving as a Compensation Committee Member.

 

Item 7.01 Regulation FD Disclosure.

 

On January 25, 2024, the Company issued a press release announcing changes to the Board described in Item 5.02 above. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

The information in this Item 7.01 and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit
Number		   Description
99.1   Press Release, dated January 25, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  OPTIMIZERX CORPORATION
     
Date: January 26, 2024 By: /s/ Edward Stelmakh
  Name:  Edward Stelmakh
  Title: Chief Financial Officer

 

 

2

 

 EX-99.1 2 ea192296ex99-1_optimizerx.htm PRESS RELEASE, DATED JANUARY 25, 2024

Exhibit 99.1

 

 

 

OptimizeRx Announces Strategic Board Changes
to Support Growth and Evolving Landscape

 

WALTHAM, MA. – January 25, 2024– OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, is pleased to announce changes to its Board of Directors reflecting a strategic move to further align with the company’s growth plans.

 

After nearly a decade of service, Gus Halas is retiring from his position as Chairperson of the Board. During his tenure, he played a pivotal role in shaping OptimizeRx’s success, and we extend our deepest gratitude for his commitment and leadership.

 

Effective immediately, Lynn O’Connor Vos will assume the role of Chairperson of the Board, succeeding Mr. Halas. Ms. Vos has been a seasoned and respected member of the OptimizeRx Board since 2015. She brings a wealth of experience and expertise, in healthcare information technology, life sciences agencies, healthcare consulting, and medical technology, to her new role and a deep understanding of the Company’s vision, making her the ideal candidate to lead the Company into the next phase of growth.

 

“As we continue to evolve as a company focused on technology enabled marketing services, we are excited to have Lynn move to Chair as Gus retires from the Board,” said Will Febbo, CEO of OptimizeRx. “As a nurse and seasoned business leader, she deeply understands the needs of both healthcare providers and patients, making her invaluable as we redefine how we engage with them. Lynn was, in fact, one of the main reasons why I joined OptimizeRx in 2015. Today, I’m more excited than ever to continue working alongside her as we build a future where patient-centric, data driven solutions drive care focused engagements and better health.”

 

“I’m thrilled to continue my journey with OptimizeRx to provide guidance and oversight on the team’s growth and commercialization strategies,” stated Ms. Vos. “I am optimistic about the Company’s ability to drive success, and I intend to support the team as they continue to be a very meaningful player with their clients and partners.”

 

Further strengthening the Board’s expertise, OptimizeRx is pleased to announce the appointment of Catherine M. Klema as a new member of the Board. Ms. Klema’s extensive experience in strategy, finance and governance, and her board experience with health systems and pharmaceutical companies, will be instrumental in helping navigate the evolving healthcare landscape.

 

“We warmly welcome Cathy to our Board of Directors,” said Mr. Febbo. “Her deep understanding of the healthcare industry, combined with her proven track record of leadership and strategic thinking, will be invaluable as we continue to grow and become highly relevant to digital commercialization for our clients.”

 

 

 

 

“I am honored to join OptimizeRx’s Board of Directors and to contribute to its ongoing success,” said Ms. Klema. “I am impressed by the Company’s commitment to innovation and its dedication to advance medication access and adherence and the impact this can have on improving patient lives. I look forward to working with the Board and management team to help OptimizeRx achieve its mission of empowering the healthcare community through tech-enabled communications solutions.”

 

These Board enhancements reflect OptimizeRx’s unwavering commitment to offer life science companies more effective ways to deliver relevant information and services to healthcare providers and their patients right at the point of care. With a sharp vision, solid financial profile, and a strengthened Board, OptimizeRx is positioned to capitalize on the immense opportunities within the healthcare technology market and continue to deliver value to patients, healthcare professionals, and investors.

 

About Lynn O’Connor Vos

 

Lynn Vos was CEO of Grey Healthcare Group for 23 years, acquired by WPP in 2017, where she led nine acquisitions to grow the company from a regional agency to a global enterprise with worldwide presence. Additionally, she has led medical device development organizations and healthcare non-profits. She currently runs a consulting firm focused on advising healthcare startups and marketing organizations.

 

Ms. Vos is also currently the Chairperson of the board of Medisafe, Inc, a patient adherence platform, and is a director of Aspira Women’s Health, Inc. (Nasdaq: AWH), a bio-analytical based company focused on the development of gynecologic disease diagnostic tools, and Modular Medical, a development stage medical device company focused on the design, development, and commercialization of innovative diabetes care technologies. She has held previous board appointments in telecommunications and healthcare non-profits.

 

About Catherine M. Klema

 

Cathy Klema has over 30 years of experience in the healthcare industry. Prior to establishing Nettleton Advisors, she served as Managing Director in the Healthcare Investment Banking groups at SG Cowen Securities and Furman Selz LLC, where she advised clients on mergers and acquisitions, divestitures, public offerings, and other strategic transactions. Ms. Klema is currently Chair of the Board of Managers of Quorum Health, a leading health system with 12 hospitals across 10 states. She also serves on the Board of Trustees of Montefiore Health System, a prominent academic health system in New York City. Previously, she was a Director of Allergan plc, a global pharmaceutical company, and Pharmaceutical Product Development, Inc., a global contract research organization.

 

About OptimizeRx 

 

OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through the most intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications. For more information, follow the Company on Twitter, LinkedIn or visit www.optimizerx.com

 

2 

 

 

Important Cautions Regarding Forward Looking Statements  

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans, future performance, expected revenues, expected Adjusted EBITDA, expected adjusted EBITDA margin and prospects. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, any synergies and other anticipated benefits of the Medicx merger may not be realized or may take longer than anticipated to be realized; the risk that the integration of OptimizeRx and Medicx will be more costly or difficult than expected; the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.

 

OptimizeRx Contact:

 

Andy D’Silva, SVP Corporate Finance  

adsilva@optimizerx.com  

 
Media Relations Contact   

 

Dilma Bennett, Media Relations Manager
dbennett@optimizerx.com


Investor Relations Contact  

 

Ashley Robinson -  LifeSci Advisors, LLC  

arr@lifesciadvisors.com  

 

 

3

 

 

 

 GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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end EX-101.SCH 4 oprx-20240124.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 oprx-20240124_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 oprx-20240124_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 24, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 24, 2024
Entity File Number 001-38543
Entity Registrant Name OptimizeRx Corporation
Entity Central Index Key 0001448431
Entity Tax Identification Number 26-1265381
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 260 Charles Street
Entity Address, Address Line Two Suite 302
Entity Address, City or Town Waltham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02453
City Area Code 248
Local Phone Number 651.6568
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 Par Value
Trading Symbol OPRX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 ea192296-8k_optimizerx_htm.xml IDEA: XBRL DOCUMENT 0001448431 2024-01-24 2024-01-24 iso4217:USD shares iso4217:USD shares false 0001448431 8-K 2024-01-24 OptimizeRx Corporation NV 001-38543 26-1265381 260 Charles Street Suite 302 Waltham MA 02453 248 651.6568 false false false false Common Stock, $0.001 Par Value OPRX NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://optimizerx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea192296-8k_optimizerx.htm oprx-20240124.xsd oprx-20240124_lab.xml oprx-20240124_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea192296-8k_optimizerx.htm": { "nsprefix": "OPRX", "nsuri": "http://optimizerx.com/20240124", "dts": { "inline": { "local": [ "ea192296-8k_optimizerx.htm" ] }, "schema": { "local": [ "oprx-20240124.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "oprx-20240124_lab.xml" ] }, "presentationLink": { "local": [ "oprx-20240124_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://optimizerx.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-24", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea192296-8k_optimizerx.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-24", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea192296-8k_optimizerx.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://optimizerx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001213900-24-006959-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-006959-xbrl.zip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end